G
Gérard Socié
Researcher at Rockefeller University
Publications - 11
Citations - 2327
Gérard Socié is an academic researcher from Rockefeller University. The author has contributed to research in topics: Graft-versus-host disease & Transplantation. The author has an hindex of 3, co-authored 11 publications receiving 2218 citations.
Papers
More filters
Journal ArticleDOI
Hematopoietic reconstitution in a patient with fanconi's anemia by means of umbilical-cord blood from an hla-identical sibling
Eliane Gluckman,Hal E. Broxmeyer,Arleen D. Auerbach,Henry S. Friedman,Gordon W. Douglas,Agnès Devergie,Helene Esperou,Dominique Thierry,Gérard Socié,Pierre Lehn,Scott Cooper,Denis English,Joanne Kurtzberg,Judith Bard,Edward A. Boyse +14 more
TL;DR: It is necessary to select patients suitable for vaginal or laparoscopic mesh placement for Fanconi's anemia preoperatively on the basis of prior history and once they provide informed consent for surgery.
AR efined Risk Score for Acute Graft-versus-Host Disease that Predicts Response to Initial Therapy, Survival, and Transplant-Related Mortality
Margaret L. MacMillan,Marie Robin,Andrew C. Harris,Todd DeFor,Paul J. Martin,Amin M. Alousi,Vincent T. Ho,Javier Bolaños-Meade,Richard Jones,Mukta Arora,Bruce R. Blazar,G. Holtan,David A. Jacobsohn,Marcelo C. Pasquini,Gérard Socié,J oseph H. Antin,John E. Levine,Daniel J. Weisdorf +17 more
TL;DR: A refined definition of acute GVHD risk is a better predictor of response, survival, and transplant-related mortality than other published acute GvHD risk scores.
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS Final Height of Patients Who Underwent Bone Marrow Transplantation for Hematological Disorders During Childhood: A Study by the Working Party for Late Effects-EBMT
Amnon Cohen,Attilio Rovelli,Boudewijn Bakker,Cornelio Uderzo,Maria-Teresa van Lint,Helene Esperou,Alberto Gaiero,Alison D. Leiper,Roland Dopfer,Jean-Yves Cahn,Franco Merlo,Hans J. Kolb,Gérard Socié +12 more
TL;DR: Iradiation, male gender and young age at BMT were found to be major factors for long-term height loss, and the majority of patients have reached adult height within the normal range of the general population.
Graft-Versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide versus Cyclosporine A and Methotrexate in Matched Sibling Donor Transplantation.
Arnon Nagler,Myriam Labopin,Bhagirathbhai Dholaria,Depei Wu,Goda Choi,Mahmoud Aljurf,Fabio Ciceri,Tobias Gedde-Dahl,Ellen Meijer,Riitta Niittyvuopio,Sergey N. Bondarenko,Jean Bourhis,Jan J. Cornelissen,Gérard Socié,Yener Koc,Jonathan Canaani,Bipin N. Savani,Gesine Bug,Alexandros Spyridonidis,Sebastian Giebel,Eolia Brissot,Ali Bazarbachi,Jordi Esteve,Mohamad Mohty +23 more
TL;DR: In this article, a registry-based study showed that post-transplant cyclophosphamide (PTCy) was associated with a higher incidence of relapse at 2-year (41.1% versus 21.3%, p=0.039) compared to CSA/MTX.
Journal ArticleDOI
Improved Outcomes of Haploidentical Hematopoietic Cell Transplantation with Total Body Irradiation-Based Myeloablative Conditioning in Acute Lymphoblastic Leukemia
Bhagirathbhai Dholaria,Myriam Labopin,Emanuele Angelucci,Johanna Tischer,Mutlu Arat,Fabio Ciceri,Zafer Gulbas,Hakan Ozdogu,Simona Sica,José Luis Díez-Martín,Yener Koc,Jiri Pavlu,Gérard Socié,Sebastian Giebel,Bipin N. Savani,Arnon Nagler,Mohamad Mohty +16 more
TL;DR: The optimal myeloablative conditioning (MAC) for patients undergoing haploidentical hematopoietic cell transplantation (haplo-HCT) is unknown.